These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26386802)

  • 1. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial.
    Pellaton C; Cayla G; Silvain J; Zeymer U; Cohen M; Goldstein P; Huber K; Pollack C; Kerneis M; Collet JP; Vicaut E; Montalescot G;
    Am Heart J; 2015 Oct; 170(4):778-86. PubMed ID: 26386802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).
    Collet JP; Huber K; Cohen M; Zeymer U; Goldstein P; Pollack C; Silvain J; Henry P; Varenne O; Carrié D; Coste P; Angioi M; Le Breton H; Cayla G; Elhadad S; Teiger E; Filippi E; Aout M; Vicaut E; Montalescot G;
    Am J Cardiol; 2013 Nov; 112(9):1367-72. PubMed ID: 24012033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
    Montalescot G; Gallo R; White HD; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1083-91. PubMed ID: 19926048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.
    Montalescot G; Zeymer U; Silvain J; Boulanger B; Cohen M; Goldstein P; Ecollan P; Combes X; Huber K; Pollack C; Bénezet JF; Stibbe O; Filippi E; Teiger E; Cayla G; Elhadad S; Adnet F; Chouihed T; Gallula S; Greffet A; Aout M; Collet JP; Vicaut E;
    Lancet; 2011 Aug; 378(9792):693-703. PubMed ID: 21856483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
    Brieger D; Collet JP; Silvain J; Landivier A; Barthélémy O; Beygui F; Bellemain-Appaix A; Mercadier A; Choussat R; Vignolles N; Costagliola D; Montalescot G
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):182-90. PubMed ID: 20578166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial.
    Liu Z; Silvain J; Kerneis M; Barthélémy O; Payot L; Choussat R; Sabouret P; Cohen M; Pollack CV; Goldstein P; Zeymer U; Huber K; Vicaut E; Collet JP; Montalescot G
    Angiology; 2017 Jan; 68(1):29-39. PubMed ID: 26861858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
    Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radial versus femoral access for angioplasty of ST-segment elevation acute myocardial infarction with second-generation drug-eluting stents.
    Marti V; Brugaletta S; García-Picart J; Delgado G; Cequier A; Iñiguez A; Hernandez-Antolin R; Serruys P; Serra A; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 Jan; 68(1):47-53. PubMed ID: 25553939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.
    Iqbal Z; Cohen M; Pollack C; Goldstein P; Zeymer U; Huber K; Barthelemy O; Cayla G; Aout M; Vicaut E; Montalescot G;
    Am J Cardiol; 2013 Jun; 111(12):1727-33. PubMed ID: 23528027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction.
    Rozenman Y; Mehran R; Witzenbichler B; Dangas G; Desaga M; Kochman J; Nilsen DW; Finkelstein A; Mosseri M; Stone GW
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E9-14. PubMed ID: 22511592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin.
    Silvain J; O'Connor SA; Yan Y; Kerneis M; Hauguel-Moreau M; Zeitouni M; Overtchouk P; Ankri A; Brugier D; Vicaut E; Ecollan P; Galier S; Collet JP; Montalescot G;
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):503-511. PubMed ID: 30144017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
    Lee MS; Wolfe M; Stone GW
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010.
    Puymirat E; Schiele F; Ennezat PV; Coste P; Collet JP; Bonnefoy-Cudraz E; Roul G; Richard P; Simon T; Danchin N
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):211-9. PubMed ID: 25075006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial.
    Bernat I; Horak D; Stasek J; Mates M; Pesek J; Ostadal P; Hrabos V; Dusek J; Koza J; Sembera Z; Brtko M; Aschermann O; Smid M; Polansky P; Al Mawiri A; Vojacek J; Bis J; Costerousse O; Bertrand OF; Rokyta R
    J Am Coll Cardiol; 2014 Mar; 63(10):964-72. PubMed ID: 24211309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial.
    Lavi S; Cantor WJ; Casanova A; Tan MK; Yan AT; Džavík V; Fitchett D; Cohen EA; Borgundvaag B; Heffernan M; Ducas J; Goodman SG
    Am Heart J; 2012 Feb; 163(2):176-81.e2. PubMed ID: 22305834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 Trial.
    Ducrocq G; Jolly S; Mehta SR; Rao SV; Patel T; Moreno R; Gao P; Steg PG
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25873729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials).
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Kirtane AJ; Palmerini T; Tarigopula M; McAndrew T; Lansky AJ; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Mar; 113(6):930-5. PubMed ID: 24440325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.